IndraLab

Statements



reach
"TBHQ treatment markedly inhibited the activation of the NLRP3 inflammasome in PA-treated HK-2 cells, as characterized by decreased NLRP3, caspase-1."

reach
"TBHQ is reported to inhibit NLRP3 inflammasome activation and consequent IL-1beta production and secretion in cerebral ischemia reperfusion injury of rats XREF_BIBR."

reach
"Consistent with all these studies, we have shown that 24 h treatment with tBHQ prior to NLRP3 inflammasome activation reduces NLRP3 inflammasome components both in WT and NOX4 KO mice (Figure 4)."

reach
"TBHQ can also inhibit the expression and activation of cell death–related proteins, i.e., NLRP3, Caspase-1, IL-18, Pro-IL-1β, and IL-1β, and there was a significant decrease in TUNEL + and NLRP3 + co-positive cells in the alveoli."

reach
"Clinically, the NLRP3 inflammasome could be a crucial therapeutic target for nasal diseases caused by PM exposure.We confirmed that tBHQ inhibits the NLRP3 inflammasome, thereby alleviating pyroptosis."

eidos
"We found that tBHQ reduced NLRP3 , p65 and TXNIP and increased TRX expression in aged EPCs ( Figure 6E , 6H , 6I ) , while silencing Nrf2 in young EPCs upregulated NLRP3 , p65 and TXNIP and downregulated TRX expression ( Figure 6E , 6J , 6K ) ."